Explaining the Recently Enacted National Alzheimer’s Project Act (NAPA)
February 4, 2011
On January 4th, the U.S. government signed NAPA into law. The passing of NAPA will bring about an integrated National plan aimed at defeating Alzheimer's disease, and it will coordinate and provide information to Alzheimer's research and services across all Federal agencies. It's also aimed at accelerating treatments that could halt, prevent, or even reverse the course of Alzheimer's disease.
NAPA will coordinate with international bodies in an effort to create deeper integration and communication in the fight against Alzheimer's disease globally.
Some of NAPA's specific goals include:
- Development of an early diagnosis
- Coordination of care and treatment of US citizens who have Alzheimer's disease,
- Eensuring that racial and ethnic populations are included in clinical research, and service efforts.
It's crucial that the administration remain committed to the promises they made when enacting NAPA, and on behalf of the millions of American's living with Alzheimer's disease, we urge the U.S. government to swiftly and successfully implement this important new law.
Learn more about the priorities of NAPA.
View all news updates for Alzheimer's disease
Disclaimer: The information provided in this section is a public service of the BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.
Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.